MedPath
NMPA Approval

Naphazoline Hydrochloride Nasal Drops

国药准字H13022122

September 29, 2020

Drug Information

盐酸萘甲唑啉滴鼻液

渤海

滴鼻剂

0.1%

化学药品

September 29, 2020

Company Information

Applicant Company

唐山市古冶区林西西道

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸萘甲唑啉滴鼻液 - NMPA 批准文号 | MedPath